This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rozhin, J. Articles by Sloane, B. F. Search for Related Content PubMed PubMed Citation Articles by Rozhin, J. Articles by Sloane, B. F.

Properties of a Plasma Membrane-associated Cathepsin B-like Cysteine Proteinase in Metastatic B16 Melanoma Variants¹

Departments of Radiation Oncology [J. R., K. V. H., B. F. S.], Biological Sciences [D. R., M. A. S., K. V. H., B. F. S.], and Pharmacology [T. T. L., R. E. R., B. F. S.], Wayne State University, and the Gershenson Radiation Oncology Center [K. V. H., B. F. S.], Harper/Grace Hospitals, Detroit, Michigan 48201

Activities of a cathepsin B-like cysteine proteinase have previously been observed to correlate with the malignancy of several animal and human tumors. Plasma membrane fractions of some of these tumors have been found to be enriched in cathepsin B-like activity. We have determined the subcellular distribution of this enzyme and three additional lysosomal hydrolases (cathepsin H, ß-hexosaminidase, and ß-glucuronidase) in normal murine liver and six metastatic variants of the B16 melanoma. The tissues were fractionated initially by differential centrifugation followed by Percoll density gradient centrifugation of the light mitochondrial fraction. Two fractions were obtained: an L-2 fraction enriched in all four lysosomal hydrolases; and an L-1 fraction enriched in a marker enzyme for the plasma membrane. Cathepsin B-like and ß-hexosaminidase activities, but not the other hydrolase activities, were also found to be enriched in the L-1 fractions of the metastatic B16 tumors.

We explored the nature of the association of the cathepsin B-like activity with the plasma membrane using fractions from the spontaneously metastatic B16 amelanotic melanoma. Activity could not be dissociated from the plasma membrane fraction by washing with a physiological salt solution suggesting that it was not adsorbed to this fraction nonspecifically, nor could it be displaced by mannose 6-phosphate or other sugars which compete for binding to the known lysosomal receptors. High salt concentrations, low concentrations of the mild detergent saponin, mild acidification, or phosphatidylinositol-specific phospholipase C did not elute the cathepsin B-like activity. However, activity was eluted by exposure to 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, a detergent used in the purification of integral membrane proteins. The B16 amelanotic melanoma plasma membrane-associated cathepsin B-like activity had a slightly higher pH optimum and was resistant to inactivation by neutral pH and to inhibition by three low molecular weight inhibitors of cysteine proteinases. The K_i values for inhibition by leupeptin and stefin A were 20-fold higher. The presence of a cathepsin B-like cysteine proteinase at the surface of metastatic tumor cells, particularly in a form which can retain activity at physiological pH and retain activity in the presence of extracellular proteinase inhibitors, may contribute to the focal dissolution of the extracellular matrix observed at sites of contact with invading tumor cells.

¹ Supported in part by USPSH Grant CA 36481 awarded by the National Cancer Institute and by a grant from Harper/Grace Hospitals.

² Recipient of Research Career Development Award CA 00921 from the National Cancer Institute. To whom requests for reprints should be addressed, at Department of Pharmacology, Wayne State University, 540 E. Canfield, Detroit, MI 48201.

Received 3/11/87. Revised 7/ 7/87. Revised 9/18/87. Accepted 9/23/87.

This article has been cited by other articles:

				S.-H. Chang, K. Kanasaki, V. Gocheva, G. Blum, J. Harper, M. A. Moses, S.-C. Shih, J. A. Nagy, J. Joyce, M. Bogyo, et al. VEGF-A Induces Angiogenesis by Perturbing the Cathepsin-Cysteine Protease Inhibitor Balance in Venules, Causing Basement Membrane Degradation and Mother Vessel Formation Cancer Res., May 15, 2009; 69(10): 4537 - 4544. [Abstract] [Full Text] [PDF]

				K. Sircar, L. Gaboury, L. Ouadi, M. Mecteau, E. Scarlata, F. Saad, A. Aprikian, S. Tanguay, S. Lapointe, C. Lussier, et al. Isolation of human prostatic epithelial plasma membranes for proteomics using mirror image tissue banking of radical prostatectomy specimens. Clin. Cancer Res., July 15, 2006; 12(14): 4178 - 4184. [Abstract] [Full Text] [PDF]

				D. Cavallo-Medved, J. Mai, J. Dosescu, M. Sameni, and B. F. Sloane Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells J. Cell Sci., April 1, 2005; 118(7): 1493 - 1503. [Abstract] [Full Text] [PDF]

				X. Que and S. L. Reed Cysteine Proteinases and the Pathogenesis of Amebiasis Clin. Microbiol. Rev., April 1, 2000; 13(2): 196 - 206. [Abstract] [Full Text] [PDF]

				B. Press, Y. Feng, B. Hoflack, and A. Wandinger-Ness Mutant Rab7 Causes the Accumulation of Cathepsin D and Cation-independent Mannose 6-Phosphate Receptor in an Early Endocytic Compartment J. Cell Biol., March 9, 1998; 140(5): 1075 - 1089. [Abstract] [Full Text] [PDF]

				D. W. Visscher, B. Sloane, W. Sakr, M. Sameni, D. Weaver, D. Bouwman, and J. D. Crissman Clinicopathologic Significance of Cathepsin B and Urokinase-type Plasminogen Activator Immunostaining in Colorectal Adenocarcinoma International Journal of Surgical Pathology, April 1, 1994; 1(4): 227 - 234. [Abstract] [PDF]

				B. Sloane, K Moin, M Sameni, L. Tait, J Rozhin, and G Ziegler Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene J. Cell Sci., January 2, 1994; 107(2): 373 - 384. [Abstract] [PDF]